Novo CEO: The pandemic has increased the value of collaborations and deals

For pharmaceutical company Novo Nordisk, the Covid-19 pandemic has been a good opportunity to optimize a string of processes in connection with partnerships and potential acquisitions.

Photo: Stine Bidstrup/Ritzau Scanpix

The Covid-19 pandemic has made a lot of things more difficult - but not everything.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs